Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads, the susceptible subpopulation is depleted causing the rate at which new cases occur to decline. Variation in individual susceptibility or exposure to infection exacerbates this effect. Individuals that are frailer, and therefore more susceptible or more exposed, have higher probabilities of being infected, depleting the susceptible subpopulation of those who are at higher risk of infection, and thus intensifying the deceleration in occurrence of new cases. Eventually, susceptible numbers become low enough to prevent epidemic growth or, in other words, herd immunity is attained. Although estimates vary, it is currently believed that herd immunity to SARS-CoV-2 requires 60-70% of the population to be immune. Here we show that variation in susceptibility or exposure to infection can reduce these estimates. Achieving accurate estimates of heterogeneity for SARS-CoV-2 is therefore of paramount importance in controlling the COVID-19 pandemic.

[1]  Joel Hellewell,et al.  Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[2]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[3]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[4]  Claire Donnat,et al.  Modeling the heterogeneity in COVID-19's reproductive number and its impact on predictive scenarios , 2020, Journal of Applied Statistics.

[5]  Mark Jit,et al.  Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..

[6]  Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: A case study in the Amazon Basin , 2020, PLoS computational biology.

[7]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[8]  Benjamin J Cowling,et al.  Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong , 2020, Nature Medicine.

[9]  Jan Hasenauer,et al.  PESTO: Parameter EStimation TOolbox , 2017, Bioinform..

[10]  G. Leung,et al.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.

[11]  A. Heidarzadeh,et al.  Seroprevalence of COVID-19 virus infection in Guilan province, Iran , 2020, medRxiv.

[12]  Aravind Srinivasan,et al.  Modelling disease outbreaks in realistic urban social networks , 2004, Nature.

[13]  Hannah Fry,et al.  Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[14]  Yiu Chung Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[15]  M. Gabriela M. Gomes,et al.  Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: A case study in the Amazon Basin , 2019, bioRxiv.

[16]  Ruifu Yang,et al.  An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China , 2020, Science.

[17]  Ken Eames,et al.  "Herd immunity": a rough guide. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  V. Colizza,et al.  Expected impact of lockdown in Île-de-France and possible exit strategies , 2020, medRxiv.

[19]  P. Klepac,et al.  Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project , 2020, medRxiv.

[20]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.

[22]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[23]  Shweta Bansal,et al.  Network frailty and the geometry of herd immunity , 2006, Proceedings of the Royal Society B: Biological Sciences.

[24]  A. Vespignani,et al.  Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.

[25]  P. Klenerman,et al.  SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) , 2021, The Lancet.

[26]  B. Horta,et al.  Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil , 2020, Nature Medicine.

[27]  M. Gomes,et al.  Introducing risk inequality metrics in tuberculosis policy development , 2018, Nature Communications.

[28]  Introducing risk inequality metrics in tuberculosis policy development , 2018 .

[29]  Sebastian Funk,et al.  Extended data: Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China , 2020 .

[30]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[31]  Yonatan H. Grad,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[32]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[33]  J. Lessler,et al.  Estimating the burden of SARS-CoV-2 in France , 2020, Science.

[34]  A. Vespignani,et al.  Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China , 2020, Science.

[35]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[36]  M. Lipsitch,et al.  A Missing Dimension in Measures of Vaccination Impacts , 2014, PLoS pathogens.

[37]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[38]  J. Tang,et al.  Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries , 2020, Journal of Infection.

[39]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[40]  Quentin J. Leclerc,et al.  Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.

[41]  W. Pegden,et al.  Frailty variation models for susceptibility and exposure to SARS-CoV-2 , 2021, medRxiv.

[42]  Frank Ball,et al.  The disease-induced herd immunity level for Covid-19 is substantially lower than the classical herd immunity level , 2020, medRxiv.

[43]  P. Alam ‘A’ , 2021, Composites Engineering: An A–Z Guide.

[44]  N. Linton,et al.  Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.

[45]  Quentin J. Leclerc,et al.  Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.

[46]  Frank Ball,et al.  A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2 , 2020, Science.

[47]  G. Gonçalves Herd immunity: recent uses in vaccine assessment , 2008, Expert review of vaccines.

[48]  W. Wei,et al.  Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[49]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[50]  J. Dushoff,et al.  The entomological inoculation rate and Plasmodium falciparum infection in African children , 2005, Nature.